Alnylam Pharmaceuticals’ Educational Grants fund independent educational projects advancing clinical knowledge in ATTR amyloidosis, AHP, and PH1.
Alnylam Pharmaceuticals funds independent educational initiatives advancing medical knowledge in rare diseases like ATTR amyloidosis, AHP, and PH1 through RFP-based grants.
Alnylam Pharmaceuticals' Sponsorships fund educational and scientific initiatives advancing research and awareness in ATTR amyloidosis, AHP, and PH1.
Alnylam Pharmaceuticals’ Collaborative Projects Support grant funds joint research and educational projects focused on advancing science in ATTR amyloidosis, AHP, and PH1.
Alnylam Pharmaceuticals' Charitable Donations support science and research initiatives by charitable organizations, with a focus on ATTR amyloidosis, AHP, and PH1.